UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Australia OKs Daewoong's P1 trial for idiopathic pulmonary fibrosis treatment
Daewoong Pharmaceutical said that it has won the go-ahead for its phase 1 c...
by Lee Han-soo
|
2019-08-22 14:36
라인
K-Hospital Fair 2019 opens 3-day show in Seoul
The K-Hospital Fair 2019 kicked off its three-day run in Seoul Wednesday. ...
by Lee Han-soo
|
2019-08-21 23:36
라인
Chong Kun Dang invests ₩5 billion in Biorchestra
Chong Kun Dang Holdings said that would invest 5 billion won ($4.1 million)...
by Lee Han-soo
|
2019-08-21 16:42
라인
‘GSK’s hair loss treatment Avodart works well for Koreans’
GlaxoSmithKline (GSK) is solidifying its position in the local hair loss ma...
by Lee Han-soo
|
2019-08-20 17:46
라인
JW’s European partner launches 3rd-gen parenteral nutrition solution in EU
JW Life Science said that Baxter Pharmaceutical, its European partner, has ...
by Lee Han-soo
|
2019-08-20 17:46
라인
Genexine, Toolgen merger deal falls through
Genexine said Tuesday it has revoked the merger agreement with Toolgen beca...
by Lee Han-soo
|
2019-08-20 11:21
라인
Combo drugs: latest trend in local pharmaceuticals
Domestic pharmaceutical companies are actively developing combination drugs...
by Lee Hye-seon
|
2019-08-19 16:02
라인
Boryung to sell antihypertensive drugs in Mexico
Boryung Pharmaceutical said the company would sell its antihypertensive com...
by Lee Han-soo
|
2019-08-19 14:31
라인
Rivalry among PARP inhibitors intense in ovarian cancer treatment
Pharmaceutical firms’ war using PARP inhibitors, a group of pharmacological...
by Kim Yun-mi
|
2019-08-19 14:00
라인
Local drugmakers speed up NASH drug development
Domestic pharmaceutical companies are rushing to develop a treatment for no...
by Lee Hye-seon
|
2019-08-16 13:52
라인
Theragen Etex turns profitable after marking record Q2 sales
Theragen Etex said Tuesday that the company and its subsidiaries recorded c...
by Lee Han-soo
|
2019-08-14 17:22
라인
AstraZeneca wins expanded indication for type 2 diabetes treatment Forxiga
AstraZeneca said that it has received an expanded indication approval for F...
by Lee Han-soo
|
2019-08-14 16:17
라인
Korean firms eyeing on growing orphan drug market
Investigational drugs developed by Korean pharmaceutical companies are incr...
by Jeong Sae-im
|
2019-08-14 14:48
라인
Huons Global hits record-high 1H sales
Huons Global said Wednesday the company and its subsidiaries recorded 209.6...
by Lee Han-soo
|
2019-08-14 14:46
라인
Court dismisses Kolon's petition to suspend government's step on Invossa
A local court has rejected a petition made by Kolon Life Science to suspend...
by Lee Han-soo
|
2019-08-14 11:57
라인
Hugel posts ₩50.3 billion in Q2 sales
Hugel said that it recorded 50.3 billion won ($41.1 million) in sales in th...
by Lee Han-soo
|
2019-08-13 18:13
라인
Last trial OKed for Eylea to prevent blindness in premature infants
The Korean drug regulator has approved a phase-3 clinical trial on Eylea (i...
by Lee Hye-seon
|
2019-08-13 12:42
라인
Daewoong's idiopathic pulmonary fibrosis treatment wins orphan drug status
Daewoong Pharmaceutical said that the U.S. Food and Drug Administration has...
by Lee Han-soo
|
2019-08-13 11:12
라인
Roche wins additional indication for breast cancer treatment Kadcyla
Roche Korea said that it has received additional indication approval for Ka...
by Lee Han-soo
|
2019-08-12 15:17
라인
Yuhan can continue testing lung cancer drug Lazertinib
Four deaths occurred during Yuhan Corp.’s clinical trial on new lung cancer...
by Lee Hye-seon
|
2019-08-12 12:58
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top